Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Klinisk medicin) hsv:(Cancer och onkologi) srt2:(2000-2004)"

Sökning: hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Klinisk medicin) hsv:(Cancer och onkologi) > (2000-2004)

Sortera/gruppera träfflistan
  • Dewyngaert, J. Keith, et al. (författare)
  • Procedure for unmasking localization information from ProstaScint scans for prostate radiation therapy treatment planning
  • 2004
  • Ingår i: International Journal of Radiation Oncology, Biology, Physics. - 0360-3016 .- 1879-355X. ; 60:2, s. 654-662
  • Tidskriftsartikel (refereegranskat)abstract
    • Purpose: To demonstrate a method to extract the meaningful biologic information from In-111-radiolabeled capromab pendetide (ProstaScint) SPECT scans for use in radiation therapy treatment planning by removing that component of the In-111 SPECT images associated with normal structures. Methods and Materials: We examined 20 of more than 80 patients who underwent simultaneous Tc-99m/In-111 SPECT scans, which were subsequently registered to the corresponding CT/MRI scans. A thresholding algorithm was used to identify Tc-99m uptake associated with blood vessels and CT electron density associated with bone marrow. Corresponding voxels were removed from the In-111 image set. Results: No single threshold value was found to be associated with the Tc-99m uptake that corresponded to the blood vessels. Intensity values were normalized to a global maximum and, as such, were dependent upon the quantity of Tc-99m pooled in the bladder. The reduced ProstaScint volume sets were segmented by use of a thresholding feature of the planning system and superimposed on the CT/MRI scans. Conclusions: ProstaScint images are now closer to becoming a biologically and therapeutically useful and accurate image set. After known sources of normal intensity are stripped away, the remaining areas that demonstrate uptake may be segmented and superimposed on the treatment-planning CT/MRI volume.
  • Edgren, M, et al. (författare)
  • Angiogenic factors: vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (b-FGF) are not necessarily elevated in patients with advanced renal cell carcinoma.
  • 2001
  • Ingår i: Anticancer research. - 0250-7005. ; 21:2B, s. 1423-9
  • Tidskriftsartikel (refereegranskat)abstract
    • Serum analysis of Vascular Endothelial Growth Factor (VEGF) and basic Fibroblast Growth Factor (b-FGF) levels were studied in 53 patients with renal cell carcinoma (RCC). Approximately 2/3 of the patients had disseminated disease at diagnosis, the remainder had no evidence of metastases. The results confirmed that VEGF has a major role in the angiogenesis of RCC. No correlation was observed between VEGF and/or b-FGF and the presence or absence of metastases, nor was any correlation observed between VEGF and/or b-FGF and patient survival. Thus, to utilise VEGF and/or b-FGF as a tumour marker at the time of diagnosis to predict patients with a high risk of progression, where an adjuvant therapeutic approach would be of great value, seems to be limited. Not all patients with RCC exhibited elevated serum levels of VEGF and/or b-FGF. No correlation was observed between tumour stage and serum levels of these angiogenic peptides.
  • Edgren, M, et al. (författare)
  • Postoperative radiotherapy after prostatectomy can be associated with severe side effects.
  • 2001
  • Ingår i: Anticancer research. - 0250-7005. ; 21:3C, s. 2231-5
  • Tidskriftsartikel (refereegranskat)abstract
    • This retrospective study was initiated to evaluate the efficacy and side effects of post-prostatectomy external beam radiation therapy (XRT) with a short time interval between surgery and irradiation in patients with prostate adenocarcinoma. Sixteen patients were investigated. The overall results in this study were 3 deaths due to recurring disease and two relapses after an average follow-up of 60 months. Severe side effects were observed. Two patients required surgical intervention due to severe post-radiotherapy side effects. The reason for this could be the high dose delivered to peripheral organs and/or a too short time interval between surgery and postoperative XRT. The results of this study confirmed that postoperative XRT can improve local control frequency in prostate carcinomas. It is recommended that the time interval between surgery and postoperative radiotherapy should to be 3-6 month.
  • Eker, Charlotta, et al. (författare)
  • Multivariate analysis of laryngeal fluorescence spectra recorded in vivo
  • 2001
  • Ingår i: Lasers in Surgery and Medicine. - John Wiley and Sons Inc.. - 0196-8092. ; 28:3, s. 259-266
  • Tidskriftsartikel (refereegranskat)abstract
    • Background and Objective: The potential of using various multivariate analysis methods for classification of fluorescence spectra acquired in vivo from laryngeal tissues in Patients was investigated. Study Design/Materials and Methods: Autofluorescence spectra were measured on 29 normal tissue sites and 25 laryngeal lesions using 337-nm excitation. Four different multivariate analysis schemes were applied. Laryngeal fluorescence spectra from patients who had been administered F-aminolevulinic acid (ALA) were obtained using 405-nm excitation and were classified using partial least squares discriminant analysis (PLS-DA). Results: For autofluorescence spectra, logistic regression based on principal component analysis (PCA) or PLS, or PLS-DA all resulted in sensitivities and specificities around 90% for lesion vs. normal. Using ALA and 405-nm excitation gave a sensitivity of 100% and a specificity of 69%. Conclusion: Multivariate analysis of fluorescence spectra could allow classification of laryngeal lesions in vivo with high sensitivity and specificity. PLS performs at least as well as PCA, and PLS-DA performs as well as logistic regression techniques on these data.
  • Forssell-Aronsson, Eva, 1961-, et al. (författare)
  • Biodistribution data from 100 patients i.v. injected with 111In-DTPA-D-Phe1-octreotide
  • 2004
  • Ingår i: Acta oncologica (Stockholm, Sweden). - 0284-186X (Print). ; 43:5, s. 436-42
  • Tidskriftsartikel (refereegranskat)abstract
    • The aim of this study was to obtain accurate data on the biodistribution of 111In-DTPA-D-Phe1-octreotide in tumour and normal tissues to facilitate dosimetric evaluations. Patients with carcinoid tumours, medullary thyroid carcinoma (MTC), differentiated thyroid tumours, endocrine pancreatic tumour (EPT), breast carcinoma, and various other tumour types were i.v. injected with 111In-DTPA-D-Phe-1-octreotide. Tumour and normal tissue samples were collected during surgery 1-35 days later, and the 111In activity concentration determined. Results showed large inter- and intra-individual variations. The 111In concentration was in general higher in carcinoids and some EPT (range 0.33-77% IA/kg) than in MTC and other tumours (0.017-7.8% IA/kg). Tumour-to-blood ratios (T/B) higher than 100 were found in most patients with carcinoids, EPT, renal carcinoma, and neuroendocrine carcinoma (max value 1500), while T/B was below 80 in most other tumours. Normal-tissue-to-blood ratios were in general < or = 10 but higher values were found in liver, kidneys, and spleen. The results presented are important for dosimetric calculations, when radiolabelled octreotide is used for diagnostic or therapeutic purposes.
  • Hugosson, J, et al. (författare)
  • Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma
  • 2004
  • Ingår i: Cancer. - John Wiley and Sons Inc.. - 1097-0142. ; 100:7, s. 1397-1405
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND. The purpose of the current study was to evaluate the effectiveness of a prostate carcinoma screening program in which serum prostate-specific antigen (PSA) levels were measured. METHODS. From a group of 20,000 men born between January 1, 1930, and December 31, 1944, 10,000 men were randomized into a screening group and 10,000 were randomized into a control group. Patients in the screening group were invited to undergo initial PSA testing between 1995 and 1996 and then were invited to receive testing every second year thereafter for 8 years (for a total of 4 PSA tests). 2 Men with PSA levels greater than or equal to 3 ng/mL (or greater than or equal to 2.54 ng/mL, in the third and fourth screening rounds) were invited to undergo clinical investigation, which included sextant 3 biopsy of the prostate. By linking to the regional cancer registry, the authors were able to obtain the true and expected incidence rates for the screening and control groups. RESULTS. The screening participation rate was high (73%). A total of 884 malignancies have been detected to date, with 640 having been detected in the screening group. There was an early and marked shift toward more favorable disease stage and grade for malignancies detected on repeat screening. In the fourth screening round, only 2 of 82 detected malignancies were classified as advanced disease. Of the 227 screen-detected tumors on which surgery was performed, only 20 (8.8%) had small volume (< 0.2 cm(3)). Forty-three interval malignancies were detected, but only five were accompanied by symptoms. At 8 years, the cumulative disease incidence rate among screening participants was 7.3%, compared with 2.4% in the control arm. The incidence rate observed in the screening population corresponds to the cumulative incidence rate observed in the Swedish male population at age 72 years. CONCLUSIONS. Biennial PSA screening was very successful in diagnosing prostate carcinoma at an early stage, when curative treatment typically is effective. In addition, the results regarding interval malignancies were favorable. Thus, decreased mortality should be observed on long-term follow-up. The lead time associated with screening appears to fall within the range described in earlier studies involving frozen sera (i.e., 5-9 years).
  • Jin, Charlotte, et al. (författare)
  • Karyotypic heterogeneity and clonal evolution in squamous cell carcinomas of the head and neck.
  • 2002
  • Ingår i: Cancer Genetics and Cytogenetics. - Elsevier. - 0165-4608. ; 132:2, s. 85-96
  • Tidskriftsartikel (refereegranskat)abstract
    • Head and neck squamous cell carcinomas (HNSCC) are often characterized by complex karyotypic changes, and a substantial proportion of the reported tumors have shown intratumor heterogeneity in the form of cytogenetically related (40%) or unrelated clones (20%). In order to study intratumor heterogeneity and to distinguish the temporal order of chromosome rearrangements in these tumors, two or more samples from different areas of the same tumor were separately examined in 19 HNSCC, yielding karyotypes from a total of 42 tumor samples. Intrasample heterogeneity was observed in 16 samples. Two samples displayed both related and unrelated multiple clones, four samples showed only multiple unrelated clones, and the remaining 10 samples had only related subclones. Intersample heterogeneity was detected in all but one tumor. Five tumors showed both cytogenetically related and unrelated multiple clones, 11 were found to have only related subclones, and the remaining two tumors showed only unrelated clones. Clonal evolution could be assessed in 13 tumors. A comparison of chromosome imbalances in different subclones from these tumors suggests that partial or entire loss of 3p, 8p, 9p, and 18q and gain of genetic material from 3q and 8q are likely to be early genetic events. In contrast, loss of 1q, 6p, 7q, and chromosome 10, as well as gain of chromosome arms 5p and 7p, are most probably later genetic events. One of the examined tumors contained two highly complex clones that were cytogenetically unrelated, indicating that this tumor had a multicellular origin.
Skapa referenser, mejla, bekava och länka
fritt online (245)
Typ av publikation
tidskriftsartikel (866)
doktorsavhandling (74)
konferensbidrag (22)
forskningsöversikt (20)
bokkapitel (12)
annan publikation (1)
visa fler...
rapport (1)
visa färre...
Typ av innehåll
refereegranskat (870)
övrigt vetenskapligt (144)
populärvet., debatt m.m. (1)
Olsson, Håkan, (50)
Borg, Åke, (43)
Li, Xinjun, (33)
Fernö, Mårten, (29)
Mertens, Fredrik, (29)
Möller, Torgil, (28)
visa fler...
Cavallin-Ståhl, Eva, (26)
Bendahl, Pär Ola, (23)
Glimelius, Bengt, (20)
Berglund, Göran, (20)
Hemminki, K (20)
Nilbert, Mef, (19)
Landberg, Göran (18)
Baldetorp, Bo, (18)
Larsson, Christer, (17)
Hemminki, Kari, (17)
Anderson, Harald (17)
Påhlman, Sven, (16)
Åkerman, Måns, (16)
Tennvall, Jan, (16)
Dasu, Alexandru (16)
Dillner, Joakim, (15)
Domanski, Henryk, (15)
Lennernäs, Bo, 1963- ... (14)
Blomqvist, Carl, (13)
Ahlman, Håkan, 1947- ... (13)
Strand, Sven-Erik, (13)
Hultborn, Ragnar, 19 ... (12)
Svanberg, Katarina, (12)
Wängberg, Bo, 1953-, (12)
Ringnér, Markus, (12)
Alvegård, Thor, (12)
Toma-Dasu, Iuliana, (12)
Axelson, Håkan, (12)
Stenram, Unne, (11)
Manjer, Jonas (11)
Mitelman, Felix, (11)
Nilsson, Ola, 1957-, (10)
Mattsson, Sören, (10)
Kjellén, Elisabeth (10)
Hallmans, Göran, (10)
Albertsson, Maria (10)
Härkönen, Pirkko, (10)
Gustafson, Pelle, (10)
Janzon, Lars, (10)
Willen, R. (10)
Dictor, Michael (10)
Wennerberg, Johan, (10)
Loman, Niklas, (10)
Jernström, Helena (10)
visa färre...
Lunds universitet (707)
Karolinska Institutet (167)
Göteborgs universitet (135)
Uppsala universitet (101)
Umeå universitet (71)
Linköpings universitet (56)
visa fler...
Örebro universitet (27)
Stockholms universitet (9)
Södertörns högskola (6)
Ersta Sköndal Bräcke högskola (3)
Kungliga Tekniska Högskolan (2)
Högskolan i Jönköping (2)
Malmö universitet (2)
Högskolan i Halmstad (2)
Linnéuniversitetet (2)
Högskolan i Skövde (1)
Högskolan i Borås (1)
Högskolan i Gävle (1)
Blekinge Tekniska Högskola (1)
Röda Korsets Högskola (1)
visa färre...
Engelska (982)
Svenska (12)
Kinesiska (1)
Annat språk (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (996)
Naturvetenskap (13)
Samhällsvetenskap (3)
Teknik (2)
Humaniora (1)


pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy